Aileron Therapeutics, Inc. (ALRN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 52.16M |
| Enterprise Value | 48.95M |
| P/E Ratio | -0.47 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.34 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.19 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.91 |
| Return On Equity | -2.58 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 1,000 |
| Net Income | -49.87M |
| Diluted EPS | -1.96 |
| Total Cash | 4.45M |
| Total Cash/Share | 0.15 |
| Total Debt | 4.92M |
| Total Debt/Equity | 0.42 |
| Current Ratio | 0.4 |
| Book Value Per Share | 0.38 |
| 52-Week Change | -56.04 |
| 52-Week High | 7.42 |
| 52-Week Low | 1.61 |
| Moving Average 50 Days | 2.37 |
| Moving Average 200 Days | 3.04 |
| Average Volume | 101,120 |
| Shares Outstanding | 21.67M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 11, 2022 |